Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N E Sharpless

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2001
p19ARF targets certain E2F species for degradationF Martelli, T Hamilton, D P Silver, et al.
Cold Spring Harbor Symposia on Quantitative Biology|May 23, 2003
The interplay between nonhomologous end-joining and cell cycle checkpoint factors in development, genomic stability, and tumorigenesisD O Ferguson, J M Sekiguchi, K M Frank, et al.
Oncogene|August 11, 2010
Somatic p16(INK4a) loss accelerates melanomagenesisK B Monahan, G I Rozenberg, J Krishnamurthy, et al.
Nature|September 7, 2001
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesisN E Sharpless, N Bardeesy, K H Lee, et al.
Molecular Cell|July 27, 2000
DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathwayK M Frank, N E Sharpless, Y Gao, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 30, 2016
Population Pharmacokinetics Modeling of Unbound Efavirenz, Atazanavir, and Ritonavir in HIV-Infected Subjects With Aging BiomarkersJ B Dumond, J Chen, M Cottrell, et al.
Leukemia|July 4, 2008
Decreased IRF8 expression found in aging hematopoietic progenitor/stem cellsD L Stirewalt, Y E Choi, N E Sharpless, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 27, 2016
p16<sup>INK4a</sup> , a Senescence Marker, Influences Tenofovir/Emtricitabine Metabolite Disposition in HIV-Infected SubjectsJ B Dumond, J W Collins, M L Cottrell, et al.
Molecular Cell|January 10, 2002
Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletionsN E Sharpless, D O Ferguson, R C O'Hagan, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2001
p19ARF targets certain E2F species for degradationF Martelli, T Hamilton, D P Silver, et al.
Cold Spring Harbor Symposia on Quantitative Biology|May 23, 2003
The interplay between nonhomologous end-joining and cell cycle checkpoint factors in development, genomic stability, and tumorigenesisD O Ferguson, J M Sekiguchi, K M Frank, et al.
Oncogene|August 11, 2010
Somatic p16(INK4a) loss accelerates melanomagenesisK B Monahan, G I Rozenberg, J Krishnamurthy, et al.
Nature|September 7, 2001
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesisN E Sharpless, N Bardeesy, K H Lee, et al.
Molecular Cell|July 27, 2000
DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathwayK M Frank, N E Sharpless, Y Gao, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 30, 2016
Population Pharmacokinetics Modeling of Unbound Efavirenz, Atazanavir, and Ritonavir in HIV-Infected Subjects With Aging BiomarkersJ B Dumond, J Chen, M Cottrell, et al.
Leukemia|July 4, 2008
Decreased IRF8 expression found in aging hematopoietic progenitor/stem cellsD L Stirewalt, Y E Choi, N E Sharpless, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 27, 2016
p16<sup>INK4a</sup> , a Senescence Marker, Influences Tenofovir/Emtricitabine Metabolite Disposition in HIV-Infected SubjectsJ B Dumond, J W Collins, M L Cottrell, et al.
Molecular Cell|January 10, 2002
Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletionsN E Sharpless, D O Ferguson, R C O'Hagan, et al.
Pageof 3